Eos Focused Equity Management L.P. increased its stake in shares of Danaher Co. (NYSE:DHR) by 1.8% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 58,266 shares of the conglomerate’s stock after buying an additional 1,015 shares during the period. Danaher accounts for about 10.0% of Eos Focused Equity Management L.P.’s portfolio, making the stock its largest holding. Eos Focused Equity Management L.P.’s holdings in Danaher were worth $7,692,000 as of its most recent filing with the SEC.
Several other hedge funds also recently made changes to their positions in DHR. Canton Hathaway LLC raised its position in shares of Danaher by 8.7% in the 1st quarter. Canton Hathaway LLC now owns 12,886 shares of the conglomerate’s stock valued at $1,701,000 after buying an additional 1,036 shares in the last quarter. Abacus Planning Group Inc. raised its position in shares of Danaher by 52.3% in the 4th quarter. Abacus Planning Group Inc. now owns 9,979 shares of the conglomerate’s stock valued at $225,000 after buying an additional 3,428 shares in the last quarter. Municipal Employees Retirement System of Michigan acquired a new position in shares of Danaher in the 4th quarter valued at approximately $1,705,000. IHT Wealth Management LLC raised its position in shares of Danaher by 5.1% in the 4th quarter. IHT Wealth Management LLC now owns 2,023 shares of the conglomerate’s stock valued at $209,000 after buying an additional 98 shares in the last quarter. Finally, Mitchell Capital Management Co. raised its position in shares of Danaher by 20.7% in the 1st quarter. Mitchell Capital Management Co. now owns 12,174 shares of the conglomerate’s stock valued at $1,607,000 after buying an additional 2,088 shares in the last quarter. 78.93% of the stock is owned by institutional investors and hedge funds.
Several equities analysts have recently commented on the stock. Piper Jaffray Companies assumed coverage on shares of Danaher in a research report on Tuesday. They issued a “neutral” rating and a $148.00 target price for the company. Wolfe Research assumed coverage on shares of Danaher in a research report on Thursday, May 30th. They issued an “outperform” rating for the company. Zacks Investment Research upgraded shares of Danaher from a “sell” rating to a “hold” rating in a research report on Monday, May 6th. Janney Montgomery Scott upped their price objective on shares of Danaher from $136.00 to $174.00 and gave the stock a “buy” rating in a research report on Wednesday, April 17th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $141.00 price objective (up from $138.00) on shares of Danaher in a research report on Wednesday, April 17th. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $133.00.
In other news, SVP William King sold 12,950 shares of the company’s stock in a transaction on Wednesday, May 29th. The shares were sold at an average price of $129.92, for a total value of $1,682,464.00. Following the sale, the senior vice president now directly owns 29,070 shares of the company’s stock, valued at approximately $3,776,774.40. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Thomas Patrick Joyce, Jr. sold 183,878 shares of the stock in a transaction on Monday, April 29th. The stock was sold at an average price of $131.30, for a total transaction of $24,143,181.40. Following the transaction, the chief executive officer now directly owns 302,377 shares in the company, valued at $39,702,100.10. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 453,448 shares of company stock worth $59,724,640. Insiders own 11.40% of the company’s stock.
NYSE DHR traded up $0.21 on Friday, hitting $139.63. The company’s stock had a trading volume of 2,297,201 shares, compared to its average volume of 2,145,888. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.74 and a current ratio of 2.18. Danaher Co. has a 1-year low of $94.59 and a 1-year high of $140.25. The stock has a market cap of $99.82 billion, a P/E ratio of 30.89, a price-to-earnings-growth ratio of 2.69 and a beta of 0.95.
Danaher (NYSE:DHR) last announced its quarterly earnings results on Thursday, April 18th. The conglomerate reported $1.07 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.01 by $0.06. Danaher had a net margin of 12.04% and a return on equity of 11.61%. The firm had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.80 billion. During the same period in the prior year, the company posted $0.99 EPS. The company’s revenue was up 3.9% on a year-over-year basis. Analysts predict that Danaher Co. will post 4.77 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.49%. The ex-dividend date of this dividend is Thursday, June 27th. Danaher’s dividend payout ratio is currently 15.04%.
COPYRIGHT VIOLATION NOTICE: This story was first published by Tech Know Bits and is owned by of Tech Know Bits. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be viewed at https://techknowbits.com/2019/06/15/eos-focused-equity-management-l-p-buys-1015-shares-of-danaher-co-dhr.html.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company’s Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Read More: Why Invest in Dividend Achievers?
Receive News & Ratings for Danaher Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Danaher and related companies with MarketBeat.com’s FREE daily email newsletter.